Literature DB >> 26759439

Aggressive eosinophilic granulomatosis with polyangiitis and transverse sinus thrombosis.

Snegha Ananth1, Rajeswari Sankaralingam2, Manesh Manoj3.   

Abstract

We report a case of a patient with eosinophilic granulomatosis with polyangiitis (EGPA, previously known as Churg-Strauss syndrome) who succumbed to respiratory failure complicated by sepsis, pneumonitis and transverse sinus thrombosis. In the absence of antineutrophilic cytoplasmic antibodies positivity, a clinical diagnosis was made based on The American College of Rheumatology-1990 criteria. Glucocorticoids, cyclophosphamide, rituximab and intravenous immunoglobulin were administered at different stages. The patient recovered momentarily after each cycle of treatment, but his vasculitis progressed and he eventually died. Cardiac or renal involvement, which is more commonly associated with an adverse outcome, was not present. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26759439      PMCID: PMC4716382          DOI: 10.1136/bcr-2015-213099

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

1.  Cerebral venous thrombosis as a rare onset of Churg-Strauss syndrome.

Authors:  Maria Teresa Sartori; Chiara Briani; Marina Munari; Pietro Amistà; Antonio Pagnan; Paolo Zampieri
Journal:  Thromb Haemost       Date:  2006-07       Impact factor: 5.249

2.  Hypereosinophilic syndrome presenting as an unusual triad of eosinophilia, severe thrombocytopenia, and diffuse arterial thromboses, with good response to mepolizumab.

Authors:  Roberto A Leon-Ferre; Catherine R Weiler; Thorvardur R Halfdanarson
Journal:  Clin Adv Hematol Oncol       Date:  2013-05

Review 3.  Churg-Strauss syndrome: evolving concepts.

Authors:  Christian Pagnoux
Journal:  Discov Med       Date:  2010-03       Impact factor: 2.970

4.  Pulmonary findings in Churg-Strauss syndrome in chest X-rays and high resolution computed tomography at the time of initial diagnosis.

Authors:  Wojciech Szczeklik; Barbara Sokołowska; Lucyna Mastalerz; Piotr Grzanka; Jacek Górka; Karolina Pacułt; Tomasz Miszalski-Jamka; Jerzy Soja; Jacek Musiał
Journal:  Clin Rheumatol       Date:  2010-07-12       Impact factor: 2.980

5.  Prothrombotic state in Churg-Strauss syndrome: a case report.

Authors:  A V Marzano; A Tedeschi; R Rossio; D Fanoni; M Cugno
Journal:  J Investig Allergol Clin Immunol       Date:  2010       Impact factor: 4.333

Review 6.  Eosinophilia and thrombophilia in churg strauss syndrome: a clinical and pathogenetic overview.

Authors:  Paul R J Ames; Maurizio Margaglione; Sara Mackie; José Delgado Alves
Journal:  Clin Appl Thromb Hemost       Date:  2009-10-14       Impact factor: 2.389

7.  Antineutrophil cytoplasmic autoantibodies and myeloperoxidase autoantibodies in clinical expression of Churg-Strauss syndrome.

Authors:  Bridget Healy; Susan Bibby; Richard Steele; Mark Weatherall; Harold Nelson; Richard Beasley
Journal:  J Allergy Clin Immunol       Date:  2012-08-22       Impact factor: 10.793

Review 8.  Eosinophils in vasculitis: characteristics and roles in pathogenesis.

Authors:  Paneez Khoury; Peter C Grayson; Amy D Klion
Journal:  Nat Rev Rheumatol       Date:  2014-07-08       Impact factor: 20.543

9.  Rituximab and cytokine release syndrome.

Authors:  Hrishikesh S Kulkarni; Pashtoon Murtaza Kasi
Journal:  Case Rep Oncol       Date:  2012-03-20

10.  Churg-Strauss syndrome associated with antiphospholipid antibodies in a patient with recurrent myocardial and cerebral ischemia.

Authors:  Marino Paroli; Alessandro Polidoro; Simone Romano; Daniele Accapezzato
Journal:  Int Med Case Rep J       Date:  2012-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.